Medical device company Interrad Medical announced its SecurAcath catheter securement device has received an Innovative Technology contract from Vizient, a health care performance improvement company.

 The contract was based on the recommendation of SecurAcath by hospital experts in this category who serve on one of Vizient’s member-led councils.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.

The SecurAcath is a subcutaneous catheter securement device. Just one SecurAcath lasts the life of the line and can significantly reduce risk of catheter-related infections, dramatically decrease catheter dislodgement and migration, decrease catheter replacement costs, and lower total cost of patient care, the company says. SecurAcath has amassed a great body clinical evidence and guidance support.

“We are very pleased the SecurAcath has been recognized by the experts to receive the Innovative Technology contract,” says Joe Goldberger, president and CEO of Interrad Medical. “We look forward to offering SecurAcath to the full Vizient membership through this contract to enhance clinical and patient care with this important medical technology.”

Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute health care providers and represents approximately $130 billion in annual purchasing volume.

“Congratulations to Interrad Medical for being awarded an Innovative Technology contract,” says Kelly Flaharty, director of contract process. “Our member council recommended SecurAcath for this contract based on the efficiencies it offers and its potential to make an incremental difference in health care.”

Through its Innovative Technology Program, Vizient works with member-led councils and task forces to review potentially innovative products. If it is determined that a product is innovative, Vizient may award a contract outside of the competitive bid cycle.

Photo: Interrad Medical